Abstract: A vehicle includes a frame, a series of tractive assemblies coupled to the frame, a cabin, and a mount. The mount includes a boss coupled to the cabin, a first bracket pivotably coupled to the boss, a second bracket coupled to the frame, and a first isolator and a second isolator extending between the first bracket and the second bracket and coupling the first bracket to the second bracket.

Abstract: A vehicle includes a frame, a series of tractive assemblies coupled to the frame, a cabin, and a mount. The mount includes a boss coupled to the cabin, a first bracket pivotably coupled to the boss, a second bracket coupled to the frame, and a first isolator and a second isolator extending between the first bracket and the second bracket and coupling the first bracket to the second bracket.

Abstract: A vehicle includes a frame, tractive assemblies engaging the frame, a cabin configured to contain at least one operator during operation of the vehicle, and a mount configured to pivotably couple the cabin to the frame. The mount includes a boss coupled to the cabin and defining a first aperture, a first bracket defining a second aperture, a pin extending through the first and second apertures, a second bracket coupled to the frame, and a pair of isolators extending between the first bracket and the second bracket. The isolators are configured to couple the first bracket to the second bracket and to reduce the transfer of vibrations between the frame and the cabin. The cabin is configured to rotate between use position and maintenance positions. The cabin is positioned near the frame in the use position and rotated away from the frame in the maintenance position.

Abstract: The invention relates to a method for producing a modified viral strain of a virus which is a member of the Reoviridae family and, in particular, relates to vaccinal viral strains of the Orbivirus genus.

Abstract: The invention relates to a method for producing a modified viral strain of a virus which is a member of the Reoviridae family and, in particular, relates to vaccinal viral strains of the Orbivirus genus.

Abstract: The invention relates to a method for producing a modified viral strain of a virus which is a member of the Reoviridae family and, in particular, relates to vaccinal viral strains of the Orbivirus genus.

Abstract: A method is disclosed for treating Spanish moss and for creating a decorative arrangement of the moss. Spanish moss is collected, treated with a pesticide, if necessary, and dried to remove substantially all moisture. The dried moss is separated into strands and draped over a cord that has been pre-treated with an adhesive binder to cause the strands of moss to adhere to the cord and create a continuous layer of moss over the length of the cord. The strands are then sprayed with adhesive that covers the strands and provides a binder that supports the strands and prevents the dried moss from deterioration. The adhesive covered layer of moss is then dried until the adhesive binder has set and is no longer tacky to the touch. Predetermined lengths of the layers of moss are then packaged for retail sale.

Abstract: An aerial image projection system (20) includes a light aircraft (22) having a parachute-wing (24) attached to a carriage (26). The system (20) further includes an on-board computing and projection unit (30) with an image projector (32) coupled to the carriage (26) and suspended below the parachute-wing (24). An image display process (98) utilizing the system (20) entails generating (100) still and/or moving images (34) in a digital format for management by the computing and projection unit (30) and projecting (102) those images (34) from the projector (32) onto the parachute-wing (24). The projection of particular images (34) may be governed by time of day, particular events, current location of aerial image projection system (20) as detected by a navigational system receiver (66) of the unit, and so forth.

Abstract: The invention relates to a method for producing a modified viral strain of a virus which is a member of the Reoviridae family and, in particular, relates to vaccinal viral strains of the Orbivirus genus.

Abstract: An aerial image projection system (20) includes a light aircraft (22) having a parachute-wing (24) attached to a carriage (26). The system (20) further includes an on-board computing and projection unit (30) with an image projector (32) coupled to the carriage (26) and suspended below the parachute-wing (24). An image display process (98) utilizing the system (20) entails generating (100) still and/or moving images (34) in a digital format for management by the computing and projection unit (30) and projecting (102) those images (34) from the projector (32) onto the parachute-wing (24). The projection of particular images (34) may be governed by time of day, particular events, current location of aerial image projection system (20) as detected by a navigational system receiver (66) of the unit, and so forth.

Abstract: The present invention provides an isolated DNA molecule encoding Malathion Carboxylesterase capable of hydrolysing at least one organophosphate selected from the group consisting of carboxylester organophosphates and dimethyloxon organophosphates. The DNA molecule comprises a nucleotide sequence having at least 60%, preferably at least 80% and more preferably at least 95% homology with Lc?E 7, in which the protein encoded by the DNA molecule differs from E 3 at least in the substitution of Trip at position 251 with an amino acid selected from the group consisting of Leu, Ser, Ala, Ile, Val, Thr, Cys, Met and Gly. The preferred substituents are Leu and Ser.

Abstract: A device and method for providing a suspended agent such as a contrast agent without mechanical resuspension. A volume of agent is divided into sub-volumes in a network of tubes, cells, sponges, grooves, etc. A propellant fluid flows through the network to release the suspended agent. The network may be internal to a container for the propellant fluid. Alternatively, the network may be adjacent an exit port of a container for the propellant fluid, or may be in-line between a propellant fluid container and a patient. The invention reduces sedimentation of agents into one or a few aggregates and eliminates a mechanical mixing step. The invention thus provides a uniformly suspended agent, improving patient health and safety and increasing cost and time savings.

Abstract: The present invention provides an isolated DNA molecule encoding Malathion Carboxylesterase capable of hydrolysing at least one organophosphate selected from the group consisting of carboxylester organophosphates and dimethylol organophosphates. The DNA molecule comprises a nucleotide sequence having at least 60%, preferably at least 80% and more preferably at least 95% homology with Lc?E 7, in which the protein encoded by the DNA molecule differs from E 3 at least in the substitution of Trip at position 251 with an amino acid selected from the group consisting of Leu, Ser, Ala, Ile, Val, Thr, Cys, Met and Gly. The preferred substituents are Leu and Ser.

Abstract: A method (22) and apparatus (20) for training a bird (24) to refrain from uttering a vocalization exceeding a predetermined acoustic level is provided. A control area (26) containing the bird (24) is illuminated with a light (32) coupled to a power source (74) through a normally-closed switch (76). A microphone (40) monitors the control area (26) and captures a sound (28) uttered by the bird (24) to produce an audio signal (86). The audio signal (86) is amplified. A discrimination unit (54) determines if the audio signal (86) exceeds a predetermined threshold (50). A timing unit (60) is triggered when the audio signal (86) exceeds the threshold (50). In response to an output (62) of the timing unit (60), a switching unit (78) opens the normally-closed switch (76) to darken the control area (26) and the bird (24) for a predetermined duration (68). After the predetermined duration (68), the switch (76) is allowed to close and the control area (26) and the bird (24) are re-illuminated.

Abstract: The present invention provides an isolated DNA molecule encoding Malathion Carboxylesterase capable of hydrolysing at least one organophosphate selected from the group consisting of carboxylester organophosphates and dimethyloxon organophosphates. The DNA molecule comprises a nucleotide sequence having at least 60%, preferably at least 80% and more preferably at least 95% homology with Lc&agr;E7, in which the protein encoded by the DNA molecule differs from E3 at least in the substitution of Trip at position 251 with an amino acid selected from the group consisting of Leu, Ser, Ala, Ile, Val, Thr, Cys, Met and Gly. The preferred substituents are Leu and Ser.

Abstract: The present invention provides an E3 esterase from an organophosphate resistant strain of L. cuprina. The invention further provides DNA sequences encoding such E3 esterases and cells transformed with the DNA sequences. In addition, the invention relates to the use of the enzyme and transformed cells as bioremediation agents.